Cargando…
IL4I1-driven AHR signature: a new avenue for cancer therapy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946875/ https://www.ncbi.nlm.nih.gov/pubmed/33692337 http://dx.doi.org/10.1038/s41392-021-00529-z |
| _version_ | 1783663122700042240 |
|---|---|
| author | Wang, Zuli Li, Tiansheng Mao, Chao Liu, Wenliang Tao, Yongguang |
| author_facet | Wang, Zuli Li, Tiansheng Mao, Chao Liu, Wenliang Tao, Yongguang |
| author_sort | Wang, Zuli |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7946875 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79468752021-03-28 IL4I1-driven AHR signature: a new avenue for cancer therapy Wang, Zuli Li, Tiansheng Mao, Chao Liu, Wenliang Tao, Yongguang Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-03-10 /pmc/articles/PMC7946875/ /pubmed/33692337 http://dx.doi.org/10.1038/s41392-021-00529-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Highlight Wang, Zuli Li, Tiansheng Mao, Chao Liu, Wenliang Tao, Yongguang IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title | IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title_full | IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title_fullStr | IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title_full_unstemmed | IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title_short | IL4I1-driven AHR signature: a new avenue for cancer therapy |
| title_sort | il4i1-driven ahr signature: a new avenue for cancer therapy |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946875/ https://www.ncbi.nlm.nih.gov/pubmed/33692337 http://dx.doi.org/10.1038/s41392-021-00529-z |
| work_keys_str_mv | AT wangzuli il4i1drivenahrsignatureanewavenueforcancertherapy AT litiansheng il4i1drivenahrsignatureanewavenueforcancertherapy AT maochao il4i1drivenahrsignatureanewavenueforcancertherapy AT liuwenliang il4i1drivenahrsignatureanewavenueforcancertherapy AT taoyongguang il4i1drivenahrsignatureanewavenueforcancertherapy |